ATE202700T1 - Verfahren zur herstellung einer clodronat- zubereitung - Google Patents

Verfahren zur herstellung einer clodronat- zubereitung

Info

Publication number: ATE202700T1
Authority: AT; Austria
Prior art keywords: clodronate; pct; tetrahydrate; disodium; disodium clodronate
Prior art date: 1993-11-12

Application number

AT95900155T

Other languages

English (en)

Inventor

Esko Pohjala

Heikki Nupponen

Kari Lehmussaari

Original Assignee

Leiras Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-12

Filing date

1994-11-11

Publication date

2001-07-15

1994-11-11 Application filed by Leiras Oy filed Critical Leiras Oy

2001-07-15 Application granted granted Critical

2001-07-15 Publication of ATE202700T1 publication Critical patent/ATE202700T1/de

Links

ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 title abstract 3
229960002286 clodronic acid Drugs 0.000 title abstract 3
238000004519 manufacturing process Methods 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
XWHPUCFOTRBMGS-UHFFFAOYSA-L disodium clodronate tetrahydrate Chemical compound O.O.O.O.[Na+].[Na+].OP([O-])(=O)C(Cl)(Cl)P(O)([O-])=O XWHPUCFOTRBMGS-UHFFFAOYSA-L 0.000 abstract 4
239000007864 aqueous solution Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
HJKBJIYDJLVSAO-UHFFFAOYSA-L clodronic acid disodium salt Chemical compound [Na+].[Na+].OP([O-])(=O)C(Cl)(Cl)P(O)([O-])=O HJKBJIYDJLVSAO-UHFFFAOYSA-L 0.000 abstract 1
239000013078 crystal Substances 0.000 abstract 1
239000007884 disintegrant Substances 0.000 abstract 1
239000000945 filler Substances 0.000 abstract 1
239000008187 granular material Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
238000012216 screening Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Medicinal Preparation (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Ceramic Products (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Detergent Compositions (AREA)
Glass Compositions (AREA)
Seasonings (AREA)
Glanulating (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Peptides Or Proteins (AREA)

AT95900155T 1993-11-12 1994-11-11 Verfahren zur herstellung einer clodronat- zubereitung ATE202700T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FI935019A FI94926C (fi)	1993-11-12	1993-11-12	Menetelmä klodronaattivalmisteen valmistamiseksi
PCT/FI1994/000509 WO1995013054A1 (en)	1993-11-12	1994-11-11	Process for preparing a clodronate preparation

Publications (1)

Publication Number	Publication Date
ATE202700T1 true ATE202700T1 (de)	2001-07-15

Family

ID=8538945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95900155T ATE202700T1 (de)	1993-11-12	1994-11-11	Verfahren zur herstellung einer clodronat- zubereitung

Country Status (25)

Country	Link
US (1)	US5776499A (de)
EP (1)	EP0727983B1 (de)
JP (1)	JPH09504800A (de)
KR (1)	KR100352155B1 (de)
CN (1)	CN1040945C (de)
AT (1)	ATE202700T1 (de)
AU (1)	AU679586B2 (de)
CA (1)	CA2175994A1 (de)
CZ (1)	CZ286132B6 (de)
DE (1)	DE69427648T2 (de)
DK (1)	DK0727983T3 (de)
ES (1)	ES2160688T3 (de)
FI (1)	FI94926C (de)
GR (1)	GR3036470T3 (de)
HU (1)	HU220633B1 (de)
IL (1)	IL111596A (de)
NO (1)	NO312938B1 (de)
NZ (1)	NZ275833A (de)
PL (1)	PL176658B1 (de)
PT (1)	PT727983E (de)
RU (1)	RU2141323C1 (de)
SK (1)	SK280552B6 (de)
TW (1)	TW436297B (de)
WO (1)	WO1995013054A1 (de)
ZA (1)	ZA948974B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI109088B (fi) *	1997-09-19	2002-05-31	Leiras Oy	Tabletti ja menetelmä sen valmistamiseksi
DE19808634A1 (de) *	1998-02-24	1999-08-26	Schering Ag	Mantel für eine pharmazeutische Zusammensetzung
AR021347A1 (es)	1999-10-20	2002-07-17	Cipla Ltd	Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
RO121891B1 (ro)	2001-07-04	2008-07-30	Sindan S.R.L.	Compoziţie farmaceutică pentru profilaxia şi tratamentul dereglărilor metabolismului calciului şi procedeu de preparare
US7862552B2 (en)	2005-05-09	2011-01-04	Boston Scientific Scimed, Inc.	Medical devices for treating urological and uterine conditions
GB0616794D0 (en)	2006-08-24	2006-10-04	Arrow Int Ltd	Solid dosage form
CN108472703B (zh) *	2015-12-22	2021-01-01	切佩茨基机械厂股份公司	使用钛合金制造棒材的方法
US11654153B2 (en)	2017-11-22	2023-05-23	Inbiomotion S.L.	Therapeutic treatment of breast cancer based on c-MAF status
TWI806467B (zh)	2022-03-03	2023-06-21	金兆豐數位科技股份有限公司	金融商品提昇報酬率多維度決策方法
IT202300007269A1 (it)	2023-04-14	2024-10-14	Univ Degli Studi Magna Graecia Di Catanzaro	Formulazione farmaceutica composta da Peptide-C associato a un bisfosfonato in forma unica e suo uso nel trattamento dell’osteosarcopenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3767998D1 (de) *	1986-12-20	1991-03-14	Boehringer Mannheim Gmbh	Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
SE501389C2 (sv) *	1992-04-24	1995-01-30	Leiras Oy	Farmaceutiskt preparat och förfarande för dess framställning
BR9307859A (pt) *	1993-05-15	1996-01-09	Boehringer Mannheim Gmbh	Comprimido com biodisponibilidade aperfeiçoada que contérn ácido

1993
- 1993-11-12 FI FI935019A patent/FI94926C/fi not_active IP Right Cessation
1994
- 1994-11-10 IL IL11159694A patent/IL111596A/en active IP Right Grant
- 1994-11-11 PL PL94314299A patent/PL176658B1/pl unknown
- 1994-11-11 DK DK95900155T patent/DK0727983T3/da active
- 1994-11-11 KR KR1019960702481A patent/KR100352155B1/ko not_active Expired - Fee Related
- 1994-11-11 EP EP95900155A patent/EP0727983B1/de not_active Expired - Lifetime
- 1994-11-11 JP JP7513620A patent/JPH09504800A/ja not_active Ceased
- 1994-11-11 CN CN94194083A patent/CN1040945C/zh not_active Expired - Fee Related
- 1994-11-11 AU AU81087/94A patent/AU679586B2/en not_active Ceased
- 1994-11-11 AT AT95900155T patent/ATE202700T1/de not_active IP Right Cessation
- 1994-11-11 HU HU9601257A patent/HU220633B1/hu not_active IP Right Cessation
- 1994-11-11 US US08/646,359 patent/US5776499A/en not_active Expired - Lifetime
- 1994-11-11 CZ CZ19961327A patent/CZ286132B6/cs not_active IP Right Cessation
- 1994-11-11 WO PCT/FI1994/000509 patent/WO1995013054A1/en not_active Ceased
- 1994-11-11 ES ES95900155T patent/ES2160688T3/es not_active Expired - Lifetime
- 1994-11-11 DE DE69427648T patent/DE69427648T2/de not_active Expired - Fee Related
- 1994-11-11 ZA ZA948974A patent/ZA948974B/xx unknown
- 1994-11-11 NZ NZ275833A patent/NZ275833A/en unknown
- 1994-11-11 CA CA002175994A patent/CA2175994A1/en not_active Abandoned
- 1994-11-11 SK SK606-96A patent/SK280552B6/sk unknown
- 1994-11-11 RU RU96113106A patent/RU2141323C1/ru not_active IP Right Cessation
- 1994-11-11 PT PT95900155T patent/PT727983E/pt unknown
- 1994-11-17 TW TW083110664A patent/TW436297B/zh not_active IP Right Cessation
1996
- 1996-05-10 NO NO19961906A patent/NO312938B1/no unknown
2001
- 2001-08-30 GR GR20010401329T patent/GR3036470T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU679586B2 (en)	1997-07-03
WO1995013054A1 (en)	1995-05-18
US5776499A (en)	1998-07-07
CZ286132B6 (cs)	2000-01-12
FI94926C (fi)	1995-11-27
TW436297B (en)	2001-05-28
ES2160688T3 (es)	2001-11-16
IL111596A0 (en)	1995-01-24
GR3036470T3 (en)	2001-11-30
ZA948974B (en)	1995-11-21
AU8108794A (en)	1995-05-29
SK280552B6 (sk)	2000-03-13
EP0727983A1 (de)	1996-08-28
DE69427648T2 (de)	2002-04-18
KR960705548A (ko)	1996-11-08
CZ132796A3 (en)	1996-10-16
HU9601257D0 (en)	1996-07-29
NO961906D0 (no)	1996-05-10
FI935019L (fi)	1995-05-13
DE69427648D1 (de)	2001-08-09
RU2141323C1 (ru)	1999-11-20
PL314299A1 (en)	1996-09-02
JPH09504800A (ja)	1997-05-13
NO961906L (no)	1996-05-23
FI94926B (fi)	1995-08-15
CN1040945C (zh)	1998-12-02
HUT75228A (en)	1997-04-28
HU220633B1 (hu)	2002-03-28
PT727983E (pt)	2001-11-30
FI935019A0 (fi)	1993-11-12
NO312938B1 (no)	2002-07-22
IL111596A (en)	1998-12-06
CN1134664A (zh)	1996-10-30
EP0727983B1 (de)	2001-07-04
SK60696A3 (en)	1997-02-05
CA2175994A1 (en)	1995-05-18
KR100352155B1 (ko)	2002-12-31
PL176658B1 (pl)	1999-07-30
DK0727983T3 (da)	2001-09-24
NZ275833A (en)	1997-10-24

Legal Events

Date	Code	Title	Description
2001-09-15	UEP	Publication of translation of european patent specification
2005-08-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE183641T1 (de)	1999-09-15	Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen
DE59504349D1 (de)	1999-01-07	Verfahren zur herstellung von wasch- oder reinigungsmitteltabletten
NO971965L (no)	1997-04-28	Farmasöytisk preparat inneholdende en smeltbar bærer og fremgangsmåte for fremstilling derav
MX9101645A (es)	1992-06-05	Mejoras en o relativas a moldes dispersables en agua
DE69427648D1 (de)	2001-08-09	Verfahren zur herstellung einer clodronat-zubereitung
DE3872143D1 (de)	1992-07-23	Verfahren zur herstellung von kaugummi.
PT98422A (pt)	1992-05-29	Processo de fabricacao d vaterite, de um derivado calcio, de mistura de vaterites e de vaterite revestida
AU639934B2 (en)	1993-08-12	Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and an amphoteric surfactant and methods for preparing same
ATE152476T1 (de)	1997-05-15	Verfahren zur herstellung von granulaten
NO960972L (no)	1996-03-08	Leirdue og en fremgangsmåte for fremstilling av denne
HUT45694A (en)	1988-08-29	Herbicide and growth-controllong compositions containing 5-amino-1-phenyl-pyrazoles as active components and process for producing the active components
ATE161423T1 (de)	1998-01-15	Verwendung von phosphinate zur behandlung der osteoporose
DE69108007D1 (de)	1995-04-13	Verfahren zur herstellung einer einen wärme-, licht- und feuchtigkeit empfindlichen wirkstoff mit einer monoklinisch kristallinen struktur enthaltenden tabletten oder dragee zusammensetzung.
ATE246515T1 (de)	2003-08-15	Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
DE68924373D1 (de)	1995-11-02	Verfahren zur Herstellung konzentrierter Granulatkörner von oberflächenaktiven Mitteln.
IL91986A0 (en)	1990-07-12	2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid,derivatives thereof and related compounds,process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
HU913009D0 (en)	1992-01-28	Method for producing inhibitors of calcium ingestion
DE69428210D1 (de)	2001-10-11	Verfahren zur herstellung von körnigen alkalinitrilotriacetat
HU910957D0 (en)	1991-10-28	Process for extracting cholesterole from egg-yolk
SU1601940A1 (ru)	1994-12-30	Способ получения искусственного карналлита
DK0612239T3 (da)	1997-05-12	Amalgam til fyldning af kaviteter og fremgangsmåde til fremstilling af sammensætninger til amalgamet
NAKAYAMA et al.	1990	Development of Rc-Vegetation Method using Continuons Fiber
JPS57174071A (en)	1982-10-26	Preparation of dressing
ATE32066T1 (de)	1988-02-15	Antihypertensive 3-aryl-1,2-benzisoxazolsulfonyl und -sulfinyl-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von medikamenten.
ZA905436B (en)	1991-04-24	Antiseptic compositions containing hexahydro-5-pyrimidinamine compounds and an amphoteric surfactant and methods for preparing same